Results 241 to 250 of about 2,626,165 (307)
Engineering and application of multiepitope recombinant proteins to enhance resistance to <i>Botrytis cinerea</i> in tomatoes: a new paradigm for creating plant immune activators. [PDF]
Front Plant SciMan X +13 more
europepmc +1 more source
Single-cycle parainfluenza virus type 5 vectors for producing recombinant proteins, including a humanized anti-V5 tag antibody. [PDF]
J Gen VirolRandall RE +8 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Recombination genes and proteins
Current Opinion in Genetics & Development, 1994The recombination of DNA takes place by a multistep process involving numerous gene products. In the past year, studies using bacterial proteins have led to a number of significant advances in our understanding of the enzymes of recombination and of the reactions that they catalyze.
H J, Dunderdale, S C, West
openaire +2 more sources
Recombination Proteins in Yeast
Annual Review of Genetics, 2004▪ Abstract The process of homologous recombination promotes error-free repair of double-strand breaks and is essential for meiosis. Central to the process of homologous recombination are the RAD52 group genes (RAD50, RAD51, RAD52, RAD54, RDH54/TID1, RAD55, RAD57, RAD59, MRE11, and XRS2), most of which were identified by their requirement for the ...
Berit Olsen, Krogh +1 more
openaire +2 more sources
Recombinant Protein Production in Yeasts
Molecular Biotechnology, 2005Recombinant DNA (rDNA) technologies (genetic, protein, and metabolic engineering) allow the production of a wide range of peptides, proteins, and biochemicals from naturally nonproducing cells. These technologies, now approx 25 yr old, have become one of the most important technologies developed in the twentieth century.
PORRO, DANILO +3 more
openaire +3 more sources
Recombinant proteins for therapy
Trends in Pharmacological Sciences, 1996Recombinant therapeutic proteins have become increasingly important over the past ten years. Numerous products derived from 20 different proteins are already on the market. In this review Peter Buckel discusses the issues surrounding the use of recombinant proteins as therapeutic agents.
openaire +2 more sources
Recombinant Protein Production in Yeasts
2004Recombinant DNA (rDNA) technologies (genetic, protein, and metabolic engineering) allow the production of a wide range of peptides, proteins, and biochemicals from naturally nonproducing cells. This technology, now approx 25 yr old, is becoming one of the most important technologies developed in the 20th century.
Porro, D, Mattanovich, D
openaire +2 more sources
Recombinant Protein Production in Yeasts
2011Recombinant protein production is a multibillion-dollar market. The development of a new product begins with the choice of a production host. While one single perfect host for every protein does not exist, several expression systems ranging from bacterial hosts to mammalian cells have been established.
Mattanovich, D +5 more
openaire +3 more sources
Insights on the Formulation of Recombinant Proteins
2019Recombinant proteins are large and complex molecules, whose therapeutic activity highly depends on their structure. Formulation of biopharmaceuticals aims at stabilizing protein conformation, promoting its efficacy, and preventing safety concerns, such as immunogenicity. Currently, the rational design of formulations is possible due to the availability
Ribeiro, Rita +4 more
openaire +3 more sources
Preparation of Recombinant Proteins in Milk
2004Using transgenic animals as the source of recombinant proteins has several specific advantages. Large amounts of proteins can be obtained, essentially from milk. These proteins are often properly processed. They are in a number of cases correctly folded, assembled, cleaved, glycosylated, gamma-carboxylated, and so on.
openaire +3 more sources